- January 28, 2016 | BY
An interview with cardiology expert Philip Sager on regulatory changes that are transforming cardiac safety testing.
- January 22, 2016 | BY
Stem cells and multiple sclerosis, an unusual deal to ensure the Ebola vaccine stockpile, a potential new planet on the horizon, and science at Davos.
- January 20, 2016 | BY
How are we faring in the global fight against neglected tropical diseases? A Q&A with Peter Hotez.
- January 19, 2016 | BY
Shedding light on data gaps that have held back the use of this research animal.
- January 15, 2016 | BY
A new global scourge, Obama’s moonshot at cancer and a proposal to use CRISPR in human embryo research.
- January 11, 2016 | BY
Recent FDA guidance on the development and validation of biomarkers was supposed to address questions about the accuracy and reliability of the data. Instead, it triggered debate
- January 8, 2016 | BY
The plight of the missing rodents, the future of optogenetics, the links between insomnia and dementia, and newcomers to the Periodic Table.
- January 7, 2016 | BY
An FDA panel steps in to resolve confusion over a standard screening tool for endotoxins. Stay tuned!
- January 4, 2016 | BY
With the growing number of citations and papers in the chemical literature, it’s not an understatement to say that the role of water molecules in drug design is a hot topic. Conceptually, it’s easy to see why.
- December 21, 2015 | BY
Rare CNS diseases are attracting more interest and research dollars in the pursuit of so-called niche-busters. CROs have a role to play.